missing translation for 'onlineSavingsMsg'
Learn More
Learn More
STEMCELL Technologies AZ628
MEK/ERK pathway inhibitor; Inhibits B-RAF, B-RAFV600E, and C-RAF-1
Brand: STEMCELL Technologies 72984
View more versions of this product
This item is not returnable.
View return policy
Description
- AZ628 is a quinazolinone that inhibits several Rapidly accelerated fibrosarcoma (RAF) kinases, including B-RAF, B-RAF V600E, and C-RAF-1 (in vitro kinase assay IC50 values of 105, 34, and 29 nM respectively; Khazak et al.) It strongly promotes B-Raf dimerization as a tight-binding inhibitor with a very slow off rate (Hatzivassiliou et al.; Lavoie et al.) From specificity profiling it is known to prevent activation of several other tyrosine kinases, including kinase insert domain receptor (KDR), discoidin domain receptor 2 (DDR2), Lck/Yes Novel (LYN), feline McDonough sarcoma (FMS), and FMS-like tyrosine kinase 1 (FLT1) (Khazak et al.)
- Inhibits tumor growth, induces cell cycle arrest and causes apoptosis in a variety of cancer cell lines, especially in lines with the B-RAF V600E mutation (McDermott et al.; Khazak et al.)
Specifications
878739-06-1 | |
10 mg | |
C27H25N5O2 | |
≥98% |